The World Health Organization was requested by Member States to develop a global priority pathogens list (global PPL) of antibiotic-resistant bacteria to help in prioritizing the research and development (R&D) of new and effective antibiotic treatments. To date, the selection of pathogens for R&D ac...tivities has been largely guided by small and large pharmaceutical companies according to a variety of parameters, such as perceived/unmet medical need, pressure of investors, market size, scientific discovery potential, and availability of specific technologies. Previous PPLs, issued by the Centers for Disease Control and Prevention.
more
PLoS ONE 7(12): e52986. doi:10.1371/journal.pone.0052986. Opern Access please download from the website
African Health Sciences 2013; 13(2): 219 - 232 http://dx.doi.org/10.4314/ahs.v13i2.4
Third Stocktaking Report, 2008
Unite for Children, Unite against AIDS
PLOS ONE | https://doi.org/10.1371/journal.pone.0196380 May 15, 2018
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0190785 January 10, 2018
Guidance Brief
Selected findings from ECDC and EMCDDA scientific guidance, 2018
PLOS ONE | DOI:10.1371/journal.pone.0172392 February 16, 2017
Practical Guidance for collaborative interventions